Literature DB >> 31679298

Antiproliferative, Immunostimulatory, and Anti-Inflammatory Activities of Extracts Derived from Mushrooms Collected in Haida Gwaii, British Columbia (Canada).

Gurbind S Deo1, Jatinder Khatra1, Sukhpreet Buttar1, Wai Ming Li1, Linda E Tackaberry2, Hugues B Massicotte2, Keith N Egger2, Kerry Reimer1, Chow H Lee1.   

Abstract

Wild mushrooms, while largely explored for their ecological significance, have not been systematically studied for their medicinal properties. This is the first report of biological activities of mushrooms from Haida Gwaii, British Columbia, Canada. The 17 mushroom species in this study were collected from multiple locations on Haida Gwaii and were screened for antiproliferative, immunostimulatory, and anti-inflammatory activities. Prior to screening, mushrooms were genetically identified and then sequentially fractionated into four crude extracts using 80% ethanol, 50% methanol, water, and 5% sodium hydroxide. We report here the strong antiproliferative and antiinflammatory activities of Amanita augusta, Phellodon atratus, Guepinia helvelloides, Chroogomphus tomentosus, Laetiporus conifericola, and Inocybe sp. In addition, A. augusta, G. helvelloides, and Inocybe sp. showed potent immunostimulatory activity. Two other species (Ganoderma tsugae and Pleurotus ostreatus) displayed strong immunostimulatory activity consistent with previous reports by others, suggesting that similar constituents are present in the same species from Haida Gwaii. For nine species (Russula paludosa, Hygrophoropsis aurantiaca, Tricholomopsis rutilans, Tyromyces chioneus, Hydnum repandum, Hypholoma fasciculare, Clavulina cinerea, P. ostreatus and Ramaria cystidiophora), we describe antiproliferative, immunostimulatory, and/or anti-inflammatory activities that have never been reported before. The new findings serve as a platform for future investigations into the potentially novel bioactive constituents of these mushrooms, as well as an incentive to further study a wider array of wild mushrooms for medicinal properties.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31679298     DOI: 10.1615/IntJMedMushrooms.2019031193

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  4 in total

1.  Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells.

Authors:  Almas Yaqoob; Wai Ming Li; Victor Liu; Chuyi Wang; Sebastian Mackedenski; Linda E Tackaberry; Hugues B Massicotte; Keith N Egger; Kerry Reimer; Chow H Lee
Journal:  PLoS One       Date:  2020-05-05       Impact factor: 3.240

Review 2.  Medicinal Properties and Bioactive Compounds from Wild Mushrooms Native to North America.

Authors:  Mehreen Zeb; Chow H Lee
Journal:  Molecules       Date:  2021-01-06       Impact factor: 4.411

3.  Characterization and phylogenetic analysis of the complete mitochondrial genome of Clavulina sp. (Cantharellales: Clavulinaceae).

Authors:  Maoling Tan; Gang Zhao
Journal:  Mitochondrial DNA B Resour       Date:  2020-07-23       Impact factor: 0.658

4.  Antioxidant and Anti-Inflammatory Activity of Five Medicinal Mushrooms of the Genus Pleurotus.

Authors:  Jan Stastny; Petr Marsik; Jan Tauchen; Matej Bozik; Anna Mascellani; Jaroslav Havlik; Premysl Landa; Ivan Jablonsky; Jakub Treml; Petra Herczogova; Roman Bleha; Andriy Synytsya; Pavel Kloucek
Journal:  Antioxidants (Basel)       Date:  2022-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.